Mariana Robles-Ledesma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mariana Robles-Ledesma has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Diego Araiza-Garaygordobil
Unidad de Cuidados Coronarios, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico
2 shared publications A P Alonso-Bringas
National Institute of Cardiology Ignacio Chavez , Mexico City , Mexico
1 shared publicationAlexandra Arias-Mendoza
Coronary Care Unit, Instituto Nacional de Cardiología ‘Ignacio Chávez’ , Juan Badiano 1, Belisario Domínguez Sección XVI, Tlalpan, 14030 Mexico City , México
1 shared publication- Alexandra Arias-Mendoza
Coronary Care Unit, National Institute of Cardiology, Mexico City, Mexico (A.A.-M.).
1 shared publication Alma Paola Alonso-Bringas
Coronary Care Unit, Instituto Nacional de Cardiología ‘Ignacio Chávez’ , Juan Badiano 1, Belisario Domínguez Sección XVI, Tlalpan, 14030 Mexico City , México
1 shared publicationD Sierra-Lara Martinez
National Institute of Cardiology Ignacio Chavez , Mexico City , Mexico
1 shared publication
Latest Publications
- 8 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 12 (7) , 413-419
Venous excess ultrasound score and acute kidney injury in patients with acute coronary syndrome
Aims: Systemic venous congestion is associated with an increased risk of acute kidney injury (AKI) in critically ill patients. Venous Excess Ultrasound Score (VExUS) has been proposed as a non-invasive score to assess systemic venous congestion. We aimed to evaluate the association between VExUS and AKI in patients with acute coronary syndrome (ACS). Methods and results: This is a prospective study including patients with the diagnosis of ACS (both ST elevation and non-ST elevation ACS). VExUS was performed during the first 24 h of hospital stay. Patients were classified according to the presence of systemic congestion (VExUS 0/≥1). The primary objective of the study was to determine the occurrence of AKI, defined by KDIGO criteria. A total of 77 patients were included. After ultrasound assessment, 31 (40.2%) patients were categorized as VExUS ≥1. VExUS ≥1 was more frequently found in inferior vs. anterior myocardial infarction/non-ST-segment elevation acute myocardial infarction (48.3 vs. 25.8 and 22.5%, P = 0.031). At each increasing degree of VExUS, a higher proportion of patients developed AKI: VExUS = 0 (10.8%), VExUS = 1 (23.8%), VExUS = 2 (75.0%), and VExUS = 3 (100%; P < 0.001). A significant association between VExUS ≥1 and AKI was found [odds ratio (OR): 6.75, 95% confidence interval (CI): 2.21–23.7, P = 0.001]. After multivariable analysis, only VExUS ≥1 (OR: 6.15; 95% CI: 1.26–29.94, P = 0.02) remained significantly associated with AKI. Conclusion: In patients hospitalized with ACS, VExUS is associated with the occurrence of AKI. Further studies are needed to clarify the role of VExUS assessment in patients with ACS.
- 8 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 12 (7) , 413-419
Venous excess ultrasound score and acute kidney injury in patients with acute coronary syndrome
Aims: Systemic venous congestion is associated with an increased risk of acute kidney injury (AKI) in critically ill patients. Venous Excess Ultrasound Score (VExUS) has been proposed as a non-invasive score to assess systemic venous congestion. We aimed to evaluate the association between VExUS and AKI in patients with acute coronary syndrome (ACS). Methods and results: This is a prospective study including patients with the diagnosis of ACS (both ST elevation and non-ST elevation ACS). VExUS was performed during the first 24 h of hospital stay. Patients were classified according to the presence of systemic congestion (VExUS 0/≥1). The primary objective of the study was to determine the occurrence of AKI, defined by KDIGO criteria. A total of 77 patients were included. After ultrasound assessment, 31 (40.2%) patients were categorized as VExUS ≥1. VExUS ≥1 was more frequently found in inferior vs. anterior myocardial infarction/non-ST-segment elevation acute myocardial infarction (48.3 vs. 25.8 and 22.5%, P = 0.031). At each increasing degree of VExUS, a higher proportion of patients developed AKI: VExUS = 0 (10.8%), VExUS = 1 (23.8%), VExUS = 2 (75.0%), and VExUS = 3 (100%; P < 0.001). A significant association between VExUS ≥1 and AKI was found [odds ratio (OR): 6.75, 95% confidence interval (CI): 2.21–23.7, P = 0.001]. After multivariable analysis, only VExUS ≥1 (OR: 6.15; 95% CI: 1.26–29.94, P = 0.02) remained significantly associated with AKI. Conclusion: In patients hospitalized with ACS, VExUS is associated with the occurrence of AKI. Further studies are needed to clarify the role of VExUS assessment in patients with ACS.
- Open Access
- 1 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 12 (Supplement)
Prevalence, clinical characteristics and factors predicting major cardiovascular events in patients with coronary artery ectasia
Funding Acknowledgements: Type of funding sources: None. Background: Coronary artery ectasia (CAE) is an uncommon angiographic finding associated with the occurrence of severe cardiovascular outcomes during the long term. However, the factors that predict major adverse cardiovascular events after the diagnosis of CAE are not well understood. Purpose: To define the prevalence, clinical characteristics and factors predicting major cardiovascular events in a large series of patients with coronary artery ectasia. Methods: Retrospective, observational, cohort study of patients who underwent coronary angiography between April 2018 and April 2021 at a national cardiovascular center in Latin America. CAE was defined as segmental dilation of a coronary artery with caliber discrepancy 1.5 greater compared to an adjacent segment. Baseline clinical variables were assessed during index hospital stay. The primary outcome of the study was the composite of cardiovascular death, acute myocardial infarction and angina. Results: Among 4,435 patients undergoing coronary angiography during the study period, 298 (6.73%) were diagnosed with CAE and constituted the final analytic sample. The main reason for performing coronary angiography was ACS (78%). Patients were mostly male (87.1%), and the prevalence of cardiovascular risk factors was high. During a median follow up of 17 months (1-151), 31 (12.0%) patients developed at least one component of the primary endpoint (Figure 1.) Bivariate analysis identified chronic kidney disease (CKD) (p=0.006) and initial presentation in the form of ACS (p<0.001) as predictors of MACE during follow up. Conclusions: In our study, we found a high prevalence of CAE. Cardiovascular risk factors during baseline evaluation were frequent; CKD and initial presentation in the form of ACS were identified as predictors for the occurrence of long term events.
- 1 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 12 (Supplement)
Open AccessPrevalence, clinical characteristics and factors predicting major cardiovascular events in patients with coronary artery ectasia
Funding Acknowledgements: Type of funding sources: None. Background: Coronary artery ectasia (CAE) is an uncommon angiographic finding associated with the occurrence of severe cardiovascular outcomes during the long term. However, the factors that predict major adverse cardiovascular events after the diagnosis of CAE are not well understood. Purpose: To define the prevalence, clinical characteristics and factors predicting major cardiovascular events in a large series of patients with coronary artery ectasia. Methods: Retrospective, observational, cohort study of patients who underwent coronary angiography between April 2018 and April 2021 at a national cardiovascular center in Latin America. CAE was defined as segmental dilation of a coronary artery with caliber discrepancy 1.5 greater compared to an adjacent segment. Baseline clinical variables were assessed during index hospital stay. The primary outcome of the study was the composite of cardiovascular death, acute myocardial infarction and angina. Results: Among 4,435 patients undergoing coronary angiography during the study period, 298 (6.73%) were diagnosed with CAE and constituted the final analytic sample. The main reason for performing coronary angiography was ACS (78%). Patients were mostly male (87.1%), and the prevalence of cardiovascular risk factors was high. During a median follow up of 17 months (1-151), 31 (12.0%) patients developed at least one component of the primary endpoint (Figure 1.) Bivariate analysis identified chronic kidney disease (CKD) (p=0.006) and initial presentation in the form of ACS (p<0.001) as predictors of MACE during follow up. Conclusions: In our study, we found a high prevalence of CAE. Cardiovascular risk factors during baseline evaluation were frequent; CKD and initial presentation in the form of ACS were identified as predictors for the occurrence of long term events.